Michèle Cavo

5 ta ish

University of Bologna

1. Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

   Nikhil C. Munshi, Larry D. Anderson, Nina Shah +25

   Maqola20217 iqtibos

   ABIABI:AkademIndex/2026.other.296878

2. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

   S. Vincent Rajkumar, Meletios Α. Dimopoulos, Antonio Palumbo +31

   Maqola20143 iqtibos

   ABIABI:AkademIndex/2026.other.466311

3. Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

   Michèle Cavo, Evangelos Terpos, Cristina Nanni +25

   Sharh maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.466312

4. Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

   Mattia D’Agostino, David A. Cairns, Juan José Lahuerta +28

   Maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.466336

5. International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma

   Hervé Avet‐Loiseau, Faith E. Davies, Mehmet Samur +43

   Maqola20252 iqtibos

   ABIABI:AkademIndex/2026.other.480252